[go: up one dir, main page]

KR900005974A - 남성의 성기능 장애 치료제 - Google Patents

남성의 성기능 장애 치료제 Download PDF

Info

Publication number
KR900005974A
KR900005974A KR1019890014067A KR890014067A KR900005974A KR 900005974 A KR900005974 A KR 900005974A KR 1019890014067 A KR1019890014067 A KR 1019890014067A KR 890014067 A KR890014067 A KR 890014067A KR 900005974 A KR900005974 A KR 900005974A
Authority
KR
South Korea
Prior art keywords
sexual dysfunction
male sexual
agent
administered
treating male
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019890014067A
Other languages
English (en)
Other versions
KR0130829B1 (ko
Inventor
골드스타인 어윈
사엔즈 드 타야다 이니고
에이. 리블렛 레슬리
Original Assignee
원본미기재
브리스톨-마이어즈 컴페니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 브리스톨-마이어즈 컴페니 filed Critical 원본미기재
Publication of KR900005974A publication Critical patent/KR900005974A/ko
Application granted granted Critical
Publication of KR0130829B1 publication Critical patent/KR0130829B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

남성의 성기능 장애 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 에토페이돈 또는 약리학적으로 허용되는 그의 산부가염의 치료상 유효량으로는 남성 성기능장애 치료제.
  2. 제1항에 있어서, 산부가염이 에토페리돈 염산염인 것이 특징인 남성 성기능장애 치료제.
  3. 제2항에 있어서, 1일 투여량이 약 50㎎-400㎎인 것이 특징인 남성 성기능장애 치료제.
  4. 제3항에 있어서, 상기의 1일 투여량을 분할하여 1일 2회 투여하는 것이 특징인 남성 성기능장애 치료제.
  5. 제3항에 있어서, 상기의 1일 투여량을 분할하여 1일 3회 투여되는 것이 특징인 남성 성기능장애 치료제.
  6. 제2항에 있어서, 음경직접 투여되는 것이 특징인 남성 성기능장애 치료제.
  7. 제6항에 있어서, 음경 발기조직에 투여되는 주사제인것이 특징인 남성 성기능장애 치료제.
  8. 제6항에 있어서, 투여량이 에토페이돈 염산염의 약 2-8㎎인 것이 특징인 남성 성기능장애 치료제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890014067A 1988-10-06 1989-09-29 남성의 성기능장애 치료제 Expired - Fee Related KR0130829B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US254,346 1988-10-06
US07/254,346 US4931445A (en) 1988-10-06 1988-10-06 Agents for treatment of male impotence

Publications (2)

Publication Number Publication Date
KR900005974A true KR900005974A (ko) 1990-05-07
KR0130829B1 KR0130829B1 (ko) 1998-04-23

Family

ID=22963939

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890014067A Expired - Fee Related KR0130829B1 (ko) 1988-10-06 1989-09-29 남성의 성기능장애 치료제

Country Status (7)

Country Link
US (1) US4931445A (ko)
EP (1) EP0362847A3 (ko)
JP (1) JP2820737B2 (ko)
KR (1) KR0130829B1 (ko)
CA (1) CA1338555C (ko)
IL (1) IL91865A (ko)
ZA (1) ZA897580B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100406772B1 (ko) * 2000-05-10 2003-11-22 이영태 점토를 이용한 경량골재

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4117249C2 (de) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
US5333621A (en) * 1993-05-28 1994-08-02 Eric Denzer Condom with transdermal vasodilator
US6007836A (en) * 1993-05-28 1999-12-28 Vericade, Inc. Transdermal vasodilator
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
US6399618B1 (en) 1997-07-09 2002-06-04 Cardiome Pharma Corp Compositions and methods for modulating sexual activity
US6451807B1 (en) 1999-04-30 2002-09-17 Lilly Icos, Llc. Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor
DE102008063728A1 (de) 2008-12-18 2010-06-24 Bayer Materialscience Ag Verfahren zur Herstellung von Isocyanaten in der Gasphase
CN106715385B (zh) 2014-09-19 2020-04-14 科思创德国股份有限公司 在气相中制备异氰酸酯的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
IT1073639B (it) * 1976-05-05 1985-04-17 Acraf Impiego del trazodone e etoperidone nel morbo di parikinson ed in altre sindromi extrapiramidali caratterizzate da tremori
US4162318A (en) * 1976-05-05 1979-07-24 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Use of trazodone and etoperidone in Parkinsonism and in other extrapyramidal syndromes characterized by tremors
US4127118B1 (en) * 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US4131675A (en) * 1978-02-09 1978-12-26 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Use of combinations of L-DOPA with trazodone and L-DOPA with etoperidone in Parkinsonism
US4687771A (en) * 1985-11-01 1987-08-18 Bristol-Myers Company Method for treatment of male impotence
FR2594335B1 (fr) * 1986-02-14 1991-09-13 Irceba Derives de 5-(2-piperazinoethyl)-thiazole en tant que medicaments utiles en urologie

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100406772B1 (ko) * 2000-05-10 2003-11-22 이영태 점토를 이용한 경량골재

Also Published As

Publication number Publication date
JP2820737B2 (ja) 1998-11-05
JPH02180828A (ja) 1990-07-13
CA1338555C (en) 1996-08-27
ZA897580B (en) 1990-07-25
EP0362847A3 (en) 1991-03-27
EP0362847A2 (en) 1990-04-11
KR0130829B1 (ko) 1998-04-23
IL91865A (en) 1993-04-04
US4931445A (en) 1990-06-05

Similar Documents

Publication Publication Date Title
DE69130529D1 (de) Behandlung von erektionversagen
KR880012218A (ko) 캘폰 유도체를 사용한 다발성 경화증의 치료방법
DE69529173D1 (de) Heterozyklische bizykeln zur behandlung von impotenz
KR910019618A (ko) 발기부전증 치료용 제약 조성물
KR970702041A (ko) 남성 발기 기능장애를 회복시키기 위한 용량형 및 이를 위한 방법(Dosage forms and method for ameliorating male erectile dysfunction)
DE69933128D1 (de) Pharmazeutische zusammensetzungen zur behandlung von erektiler dysfunktion
KR920012113A (ko) 펩타이드 유도체의 사용방법
KR930702000A (ko) 노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용
KR920703043A (ko) 진해제로서의 gaba-b 선택적 효능제의 용도
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
KR900005974A (ko) 남성의 성기능 장애 치료제
KR900004338A (ko) 5-(4-클로로페닐)-2,4- 디메틸-3h-1,2,4- 트리아졸-3-티온을 이용한 혈소판증가증의 치료방법
KR950007848A (ko) (S)-(-)-α-에틸-2-옥소-1-피롤리딘아세트아미드를 사용한 불안치료방법
KR930000114A (ko) 지방산을 이용한 치료
ATE293451T1 (de) Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin
KR940018087A (ko) 진통제 및 소염제로서의 6-클로로-5-플루오로-3-(2-테노일)-2-옥신돌-ⅰ-카복스아미드
HUP9902094A2 (hu) PGE-1-tartalmú liofilizált liposzómák erekciós zavar kezelésében való alkalmazásra
KR900007424A (ko) 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
PT1027053E (pt) Metodo de prevencao de nefrotoxicidade provocada por ciclosporinas e tacrolimus
KR950016760A (ko) 치질 치료제
KR920000326A (ko) 사람에 있어서 몰핀 및 동족체의 진통 효과에 대한 내성 발생을 방지하기 위한 gm₁모노시알로강글리오사이드 및 이의 내부 에스테르 유도체의 용도
KR920019350A (ko) 자기면역질환요법을 위한 약제조성물
KR900011461A (ko) 트립스타틴을 유효성분으로 하는 치료제
KR900007434A (ko) 시스타틴을 유효 성분으로하는 치료제
KR910009267A (ko) 우울증의 치료방법

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

FPAY Annual fee payment

Payment date: 20051213

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20061125

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20061125

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000